Insufficient scRNA-seq data for expression of IL5 at single-cell level.
Insufficient scRNA-seq data for expression of IL5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 87% | 4.22 | 157 / 180 | 0% | 0 | 0 / 430 |
uterus | 85% | 3.49 | 145 / 170 | 1% | 0.01 | 3 / 459 |
blood vessel | 78% | 3.18 | 1045 / 1335 | 0% | 0 | 0 / 0 |
intestine | 75% | 2.50 | 726 / 966 | 1% | 0.02 | 7 / 527 |
brain | 75% | 3.04 | 1993 / 2642 | 0% | 0.01 | 3 / 705 |
thymus | 72% | 2.27 | 471 / 653 | 0% | 0 | 0 / 605 |
prostate | 71% | 2.49 | 173 / 245 | 1% | 0.02 | 4 / 502 |
lung | 69% | 2.96 | 399 / 578 | 2% | 0.08 | 23 / 1155 |
bladder | 67% | 2.24 | 14 / 21 | 2% | 0.07 | 10 / 504 |
adipose | 65% | 1.85 | 785 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 63% | 2.07 | 915 / 1445 | 1% | 0.01 | 1 / 183 |
breast | 63% | 2.01 | 287 / 459 | 1% | 0.03 | 12 / 1118 |
stomach | 58% | 1.66 | 208 / 359 | 1% | 0.03 | 3 / 286 |
muscle | 58% | 1.44 | 462 / 803 | 0% | 0 | 0 / 0 |
kidney | 54% | 1.40 | 48 / 89 | 1% | 0.05 | 5 / 901 |
adrenal gland | 54% | 1.31 | 139 / 258 | 0% | 0 | 0 / 230 |
heart | 53% | 1.27 | 455 / 861 | 0% | 0 | 0 / 0 |
liver | 50% | 1.06 | 112 / 226 | 0% | 0 | 0 / 406 |
spleen | 49% | 1.14 | 119 / 241 | 0% | 0 | 0 / 0 |
pancreas | 43% | 0.99 | 142 / 328 | 0% | 0 | 0 / 178 |
skin | 41% | 0.91 | 740 / 1809 | 0% | 0 | 0 / 472 |
peripheral blood | 23% | 0.60 | 214 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071803 | Biological process | positive regulation of podosome assembly |
GO_0006955 | Biological process | immune response |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006954 | Biological process | inflammatory response |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0045645 | Biological process | positive regulation of eosinophil differentiation |
GO_0038043 | Biological process | interleukin-5-mediated signaling pathway |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005137 | Molecular function | interleukin-5 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0008083 | Molecular function | growth factor activity |
Gene name | IL5 |
Protein name | Interleukin-5 (IL-5) (B-cell differentiation factor I) (Eosinophil differentiation factor) (T-cell replacing factor) (TRF) Interleukin-5 (Eosinophil differentiation factor) |
Synonyms | |
Description | FUNCTION: Homodimeric cytokine expressed predominantly by T-lymphocytes and NK cells that plays an important role in the survival, differentiation, and chemotaxis of eosinophils . Acts also on activated and resting B-cells to induce immunoglobulin production, growth, and differentiation (By similarity). Mechanistically, exerts its biological effects through a receptor composed of IL5RA subunit and the cytokine receptor common subunit beta/CSF2RB . Binding to the receptor leads to activation of various kinases including LYN, SYK and JAK2 and thereby propagates signals through the RAS-MAPK and JAK-STAT5 pathways respectively . . FUNCTION: Homodimeric cytokine expressed predominantly by T-lymphocytes and NK cells that plays an important role in the survival, differentiation, and chemotaxis of eosinophils. Acts also on activated and resting B-cells to induce immunoglobulin production, growth, and differentiation. Mechanistically, exerts its biological effects through a receptor composed of IL5RA subunit and the cytokine receptor common subunit beta/CSF2RB. Binding to the receptor leads to activation of various kinases including LYN, SYK and JAK2 and thereby propagates signals through the RAS-MAPK and JAK-STAT5 pathways respectively. . |
Accessions | C9JQP9 ENST00000231454.6 P05113 ENST00000450655.1 |